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Objective. To compare hearing and speech understanding between a new, nonskin penetrating Baha system (Baha Attract) to
the current Baha system using a skin-penetrating abutment. Methods. Hearing and speech understanding were measured in 16
experienced Baha users. The transmission path via the abutment was compared to a simulated Baha Attract transmission path by
attaching the implantable magnet to the abutment and then by adding a sample of artificial skin and the external parts of the Baha
Attract system. Four different measurements were performed: bone conduction thresholds directly through the sound processor
(BC Direct), aided sound field thresholds, aided speech understanding in quiet, and aided speech understanding in noise. Results.
The simulated Baha Attract transmission path introduced an attenuation starting from approximately 5 dB at 1000Hz, increasing to
20–25 dB above 6000Hz. However, aided sound field threshold shows smaller differences and aided speech understanding in quiet
and in noise does not differ significantly between the two transmission paths. Conclusion. The Baha Attract system transmission
path introduces predominately high frequency attenuation. This attenuation can be partially compensated by adequate fitting of
the speech processor. No significant decrease in speech understanding in either quiet or in noise was found.
1. Introduction
With more than 100,000 implantations so far, bone anchored
hearing implants [1] belong to the widest used implantable
hearing aids to date, second only to cochlear implants. The
principle of operation is shown in Figure 1(a): a skin pene-
trating abutment is attached to an osseointegrated titanium
implant. A sound processor is then attached to the abutment
using a snap coupling which can be adjusted or removed
by the user. Although each part of the system has been
improved considerably in the last years [2–4], the basic design
principle has now been in use for over 3 decades [5]. Its
attractiveness is based on the relatively simple surgery and on
the excellent results in adults and children with conductive
or mixed hearing loss or, more recently, also in single sided
deafness [6–8].
Despite this success, some drawbacks are well known.
One of them is a tendency to low-grade infections around
the abutment [9, 10], another personal preference, and cos-
metic factors. Some patients who could benefit significantly
from a system such as the Baha depicted in Figure 1(a)
decline because of the skin penetrating implant behind the
ear.
Several solutions, in which the skin remains intact, have
been proposed. The Xomed Audiant system [11] in the 1980s
had an implanted magnet, but the coil of the transducer
was built into the sound processor. The maximal output of
the system proved to be too low for numerous patients [11],
and the system was discontinued. The Sophono system [12]
is available today and is based on two implanted magnets
within a single implant [13]. The sound processor with the
bone conduction transducer (vibrator) is attached externally
over the intact skin. The contact area between the skull and
the implant is relatively large (more than 2.5 cm2) and new
research suggests that its output is 10–15 dB lower than that
of the Baha [14].
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Figure 1: (a) Current Baha system with skin penetrating abutment. (b) Nonskin penetrating Baha Attract system with magnetic retention.
Recently, a new bone conduction implant, the Vibrant
Bonebridge [15], has been introduced. In contrast to the other
systems described so far, the transducer is fully implanted and
connected to the speech processor via a radiofrequency link.
The implant is significantly larger and more expensive than
any of the others.
Very recently, a new system called Baha Attract has been
proposed. It is shown schematically in Figure 1(b). It uses the
same types of sound processors and the same osseointegrated
titanium implant as the current Baha system. This results
in a small contact area between the skull and the implant.
Two magnetic discs are used: one with a diameter of 27.0mm
below the intact skin and another with a diameter of 29.5mm,
to which the external sound processor is attached.The choice
of such a relatively large contact area results in lower skin
pressures to achieve the necessary retention force.
So far, little is known about the practically important
audiologic aspects of this new system and we are not aware
of any peer reviewed reports or investigations. The change of
the transmission path from direct bone conduction through
the abutment to transmission via soft tissue might introduce
differences in the acoustic transmission, most probably an
additional attenuation. However, its extent and consequences
for speech understanding are not known. A part of this
attenuation may be compensated by different setting of the
sound processor, but possibly not all of it.
The aim of this investigation is threefold. The primary
aim is to compare the proposed Baha Attract transmission
path to the conventional path shown in Figure 1(a) in actual
Baha users. Hearing thresholds and speech understanding
measured through the system are the pertinent endpoints.
The second aim is to estimate the hearing thresholds, at
which candidatesmay be expected to experience significantly
decreased speech understanding when deciding whether to
choose a Baha Attract system instead of the skin penetrating
solution.
The third aim is to ascertain that the differences in hearing
between the two transmission paths are comparable for the
two most important groups of Baha users: those with a
conductive/mixed hearing loss [3] and those with single-
sided sensorineural deafness (SSD) [8]. As all changes in the
transmission path take place prior to sound entering the skull,
we hypothesize that the attenuation and therefore the impact
on speech understanding should be similar in both user
groups. However, to date there is no experimental evidence
to support this hypothesis.
2. Materials and Methods
2.1. Subjects. 16 adult Baha users aged 30–75, mean 58.4
years, 6 females and 10 males, participated in the study.
All had an implant with a skin penetrating abutment,
as shown in Figure 1(a), for a period between 6 months
and 22 years (average 8.9 years, 7 right, 9 left) and
used a Baha sound processor on a daily basis at the
BioMed Research International 3
0
20
40
60
80
120
100
250 500 1000 2000 3000 4000 6000 8000
Baha ear
Frequency (Hz)
G
ro
up
 M
IX
0
20
40
60
80
120
100
0
20
40
60
80
120
100
250 500 1000 2000 3000 4000 6000 8000
Contralateral ear
Frequency (Hz)
H
ea
rin
g 
lo
ss
 (d
B 
H
L)
0
20
40
60
80
120
100
0
20
40
60
80
120
100
250 500 1000 2000 3000 4000 6000 8000
Baha ear
Frequency (Hz)
G
ro
up
 S
SD
0
20
40
60
80
120
100
0
20
40
60
80
120
100
250 500 1000 2000 3000 4000 6000 8000
Contralateral ear
Frequency (Hz)
H
ea
rin
g 
lo
ss
 (d
B 
H
L)
H
ea
rin
g 
lo
ss
 (d
B 
H
L)
H
ea
rin
g 
lo
ss
 (d
B 
H
L)
0
20
40
60
80
120
100
Figure 2: Pure tone audiograms of the two study subgroups MIX and SSD. Solid lines denote mean AC thresholds, broken lines mean BC
thresholds, and error bars show the range.
time of testing (6 Baha BP110, 5 Baha BP100, 3 Baha
Intenso, 1 Baha Divino, and 1 Baha Compact [3, 4, 16]).
Eight subjects had a mixed or conductive hearing loss
and this group is labelled MIX throughout the text. The
other 8 subjects had a single-sided sensorineural deafness.
This group is labelled SSD throughout the text. Figure 2
shows a synopsis of the unaided air conduction (AC)
and bone conduction (BC) hearing thresholds for both
groups.
2.2. Transmission Paths. Four different transmission paths
were compared in this study. They are labelled “Abutment,”
“Magnet 3,” “Magnet 5,” and “Testband.” Figure 3 shows a
schematic representation of these paths. A Baha BP110 sound
processor [4] (Cochlear Inc., Sweden) was used for all tests
and all participants.
In the “Abutment” setting, the BP110 sound processor was
attached directly to the patient’s own abutments, as shown in
Figure 3(a).
In the “Magnet 3” and “Magnet 5” settings, shown in
Figure 3(b), a magnetic plate (diameter 27.0mm, thickness
2.4mm) was attached to the snap coupling. An artificial
skin sample (SawBones 1485-150, Sweden, diameter 28mm,
thickness 5.6mm) was placed directly above it.The thickness
of this sample is very close to the average skin thickness of
5.5mm on the mastoid found by Faber et al. [10]. Then the
Baha Attract sound processor magnet (diameter 29.5mm,
thickness 5.1mm) was placed above the artificial skin sample
and the BP110 sound processor was attached to its snap
coupling.
Five different processor magnets are available, labelled 1
through 5 by the manufacturer according to their magnetic
strength. In this investigation, Magnet 3 was used as it was
the weakest one that was held in place sufficiently for the
experiments without falling off. Its measured retention force
in the experimental setup was 0.87N.
In the “Magnet 5” setting, the strongest magnet available
was used. Its retention force in the experimental setting was
measured to be 1.24N.
In the “Testband” setting, depicted schematically in
Figure 3(c), the BP110 sound processor was mounted on a
standard Baha testband [17]. The plastic disc of the testband,
which holds the sound processor, is shown schematically in
Figure 3(c). It was placed immediately behind the patient’s
implant, but without touching the abutment. The “Testband”
condition was included because it is simple, is frequently
used preoperatively at many centers, and is expected to show
similar results as the Baha Attract transmission path.
2.3. Study Protocol. The study protocol was approved by the
local Ethical Committee of Bern. All tests were performed
at the University Hospital of Bern in accordance with the
declaration of Helsinki and all participants had given their
informed consent prior to inclusion in the study.
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Figure 3: Transmission paths compared in the study. (a) “Abutment,” (b) “Magnet 3” and “Magnet 5,” and (c) “Testband” individual parts:
(1) implant, (2) abutment, (3) sound processor BP110, (4) internal magnet, (5) artificial skin, (6) external magnet plate, and (7) testband (only
the disc is shown, and the headband, which is attached to the disc, is not shown).
The measurements took approximately 5 hours per sub-
ject and were completed within one day for all but one
participant. For each subject, AC and BC threshold were
measured first in both ears. BC thresholds were measured
between 250Hz and 8000Hz. Scale-out values were marked.
They were rare, except for the poorer ear of the SSD
group, as shown in the bottom left panel of Figure 2, where
scale-out values were replaced by the audiometer limits for
graphical purposes. Then unaided sound field thresholds
were measured. For all sound field measurements, that is,
aided and unaided, the ear contralateral to the Baha implant
was plugged with an ear plug (E-A-Rsoft, 3M, Sweden) and
covered with a Peltor Optime II hearing protector (Aero Ltd.,
Poynton, UK).
Then, hearing and speech understanding with each of the
4 transmission paths described in Section 2.2 were tested.
The order of the transmission paths was varied systematically
between subjects to minimize effects of training or fatigue.
For each new transmission path, first BC thresholds were
measured directly via the BP110 sound processor (so-called
BC Direct [18]). Then the processor was fitted according
to the manufacturer’s instructions, with the individually
measured BC Direct values serving as the starting point.
Version 2.0 SR 2 of the Cochlear Fitting software was used for
all fittings. All automatic algorithms such as noise reduction
or automatic directionality were switched off. For all tests,
the everyday program was used with the following settings:
microphone set to omnidirectional mode, feedback manager
set to default, and position compensation set to “on.” No
additional fine tuning was administered.
After an acclimatization period of 30 minutes, the fol-
lowing three measurements were performed in the sound
field: (1) aided thresholds using narrow band noise, (2) aided
speech understanding in quiet using German monosyllabic
words (Freiburger word test) at a presentation level of 65 dB
SPL, and (3) aided speech understanding in noise using the
German Oldenburger sentence test (OLSA) [19]. The OLSA
uses an adaptive test procedure to estimate the signal-to-noise
ratio (SNR) required for 50% speech understanding. It con-
sists of 40 lists of 30 test sentences each and an accompanying
noise signal (speech babble) generated by superimposing all
test items. The noise level was held constant at 65 dB SPL
and the presentation level of the test sentences was varied
adaptively according to the number of correctly repeated
words, as prescribed by the predefined OLSA test paradigm
[19]. Two training lists were administered before the actual
testing. The results of the training lists were not used.
2.4. Test Rooms and Test Equipment. All measurements
took place in a double-walled sound attenuating chamber
(6.0 × 4.1 × 2.2m) with an almost frequency independent
average reverberation time of 0.14 s. Speech in quiet and
sound field thresholds measurements were measured with a
clinical audiometer (GSI61; Grason-Stadler, Mildford, NH,
USA) using an active loudspeaker (Type 1030A, Genelec,
Iisalmi, Finland) placed 1m in front of the listener. For
speech understanding in noise, an Audiobox amplifier (Merz
Medizintechnik, Reutlingen, Germany) and a Control 1 Pro
loudspeaker (JBL Ins., CA, USA) positioned at a distance of
1m from the listener was used.
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2.5. Statistical Analysis. Results were analyzed using Prism
5 and Instat 3.10 (both from GraphPad Inc., La Jolla, CA,
USA). The Friedman test (repeated measures nonparametric
ANOVA) and Dunn’s comparisons as posttests were used
for comparisons between the different transmission paths.
Mann-Whitney tests were used for comparisons between the
MIX and the SSD group in Section 3.4. All statistical analyses
were either performed or supervised by a certified statistician
(last author Martin Kompis).
3. Results
3.1. Hearing Thresholds through the Different Transmission
Paths. Hearing thresholds were measured twice through
each of the 4 transmission paths: once using BC Direct, that
is, measuring the BC thresholds with the sound processor as
the signal generator, and once as aided sound field thresholds,
where the sound processor acts as a hearing amplifier in
its clinically intended way. The most important difference
between the twomeasureswas that any additional damping in
the transmission pathmay be compensated by suitably fitting
the sound processor in the sound field measurement, but not
in BC Direct measurement.
Figure 4 shows the BC Direct thresholds of all 16 partic-
ipants. Below 1000Hz, all thresholds are similar and no sta-
tistically significant differences are found (𝑃 > 0.05). Above
1000Hz, the Friedman test shows significant differences (𝑃 ≤
0.0072). The posttests reveal that the difference lies between
the better threshold with the abutment and the other 3
transmission paths, but not between Magnet 3, Magnet 5,
and the Testband. The difference between the abutment and
the other 3 paths lies between 11.9 dB and 23.3 dB for the
frequency range of 4 to 8 kHz.
Figure 5 shows the sound field thresholds in the unaided
and in the aided condition using all 4 transmission paths. For
all aided conditions and at all frequencies, the aided thresh-
olds are significantly better than the unaided thresholds. Stars
denote statistically significant differences (𝑃 < 0.05) between
the aided conditions.
Aided thresholds are similar in the middle frequency
range (500 to 2000Hz) but differ at 250Hz (𝑃 = 0.0016) and
above 3000Hz (𝑃 < 0.011). Again, the statistical posttests
show that it is the difference between the abutment and the
other conditions, and not between the 3 other transmission
paths, which is statistically significant. In the frequency range
4000 to 8000Hz, the difference between the abutment and
the other 3 transmission paths is smaller by approximately
3 dB than that for the BC Direct measurement in Figure 4.
3.2. Aided Speech Understanding. Figure 6 shows the results
for aided speech understanding in quiet at a presentation
level of 65 dB. Average scores decrease from the abutment
setting to the testband (difference of 17% points) with the
scores for “Magnet 3” and “Magnet 5” lying in between.
Despite substantial variations between the participants, the
differences are statistically significant (Friedman test 𝑃 =
0.01). Dunn’s posttests reveal that the difference between
“Abutment” and “Magnet 5” as well as between “Abutment”
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Figure 5: Unaided and aided sound field thresholds. Stars denote
statistically significant difference (𝑃 < 0.05) between the 4 aided
thresholds (4 transmission paths) at the given frequency.
and “Testband” is significant (𝑃 < 0.05). No significant
difference was found between Magnet 3 and Magnet 5.
Figure 7 shows the results for speech understanding in
noise. Here, lower SNRs denote better speech understanding
in noise. The differences between the means are small (max
difference 2.0 dB) but still statistically significant (𝑃 = 0.02).
The posttests show that the significant (𝑃 < 0.05) differences
are between “Abutment” and “Testband” and between “Test-
band” and “Magnet 5.” Again, no significant difference was
found between “Magnet 3” and “Magnet 5.”
3.3. Relationship between Unaided BC Thresholds and Speech
Understanding. The attenuation introduced by the Baha
Attract system can be partially compensated by proper adjust-
ment of the sound processor. This can be seen by comparing
Figures 4 and 5. Users with relatively good BC hearing
thresholds can therefore be expected to experience only small
6 BioMed Research International
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lines denote mean values and standard deviations. Stars denote
statistically significant differences (𝑃 < 0.05).
or even no detrimental effect from using the Baha Attract
system. In the higher frequency range, compensation is only
partial (Figure 5). It is conceivable that mainly users with
a more pronounced hearing loss might suffer a noticeable
decrease in speech understanding when choosing a Baha
Attract system instead of the current solution with the skin
penetrating abutment.
Aided thresholds and aided speech understanding are
known to correlate well with the BC threshold of the better
ear [20]. This correlation is better than the correlation with,
for example, AC thresholds or with the BC threshold of
the poorer ear [20]. The largest difference between the
“Abutment” and the “Magnet” transmission paths shows in
the high frequency region above 3000Hz. Figure 8 shows
the loss of speech understanding when changing from the
“Abutment” to the “Magnet 3” transmission as a function of
the average BC thresholds at 4, 6, and 8 kHz. Scale-out was
observed in 4 subjects at 6 or 8 kHz, never at 4 kHz. In cases
of scale-out, audiometer limits were used. This may lead to a
small compression at the right side of the graph in Figure 8
when compared to the real, but not readily measurable BC
thresholds of these few subjects.
Both parts of the figure show the data points for each
participant and an exponential (nonlinear) fit. There is a
substantial spread of individual data points. Nevertheless, a
tendency towards higher SNRs required for speech under-
standing in noise can be seen starting from around 40 dB
average BC hearing loss. For speech in quiet (lower panel
of Figure 8), there is a drop that similarly starts to be
clinically significant around an average BC hearing loss of
approximately 30 to 45 dB.
3.4. Single Sided Deafness versus Mixed Hearing Loss. So far,
all data of the SSD and of the MIX group were pooled and
analyzed together. This is based on the hypothesis, that the
change in the transmission path should affect patients in both
groups similarly, previously discussed.
To test whether this hypothesis can be substantiated by
our data, the difference between the 2 groups of patients
(MIX and SSD)was analyzed. For each of the 4measurements
(BC Direct, aided sound field thresholds, speech in quiet,
and speech in noise), the difference between the “Abutment”
and the “Magnet 3” setting was analyzed. Data for “Magnet
3” rather than for “Magnet 5” are shown here, as these
differences might be expected to be larger due to the weaker
coupling to the skin, although no significant differences
between the two magnets were found in our data.
For the BC Direct thresholds over the 8 frequencies 250,
500, 1000, 2000, 3000, 4000, 6000, and 8000Hz, the average
difference between “Abutment” and “Magnet 3” ranges from
−6.9 dB to +25.5 for the SSD group and between −1.9 dB
and +26.3 dB for the MIX group. Even before correction for
multiple testing, the difference between the two groups is
not statistically significant at any of the 8 frequencies (Mann-
Whitney test, 𝑃 = 0.37 to 0.99).
Similarly, for aided sound field thresholds over the same 8
frequencies between 250 and 8000Hz, the average difference
between “Abutment” and “Magnet 3” ranges from −6.3 dB to
+18.1 for the SSD group and between −1.9 dB and +23.1 dB for
the MIX group. Again, even before correction for multiple
testing, the difference between the two groups is not statis-
tically significant at any of the 8 frequencies (Mann-Whitney
test, 𝑃 = 0.22 to 0.62).
Table 1 summarizes the comparison between the SSD
group and the MIX group for speech in quiet and for speech
in noise. Again, the differences between theMIX and the SSD
groups are not statistically significant for either speech test.
4. Discussion
Our data suggest that the nonskin penetrating Baha Attract
system should be helpful and beneficial for patients. Although
on average speech understanding in quiet does decrease,
if compared to the direct bone conduction through the
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Table 1:The difference (decrease) in speech understanding between the “Abutment” and the “Magnet 3” transmission paths is not statistically
significantly different between the two subgroups SSD and MIX either in quiet or in noise.
Measurement Group SSD(mean ± SD)
Group MIX
(mean ± SD) Difference between groups
Speech in quiet 15.0 ± 20.8% 6.6 ± 8.3% 8.4% (𝑃 = 0.75)
Speech in noise −0.8 ± 1.8 dB 0.2 ± 2.9 dB −1.0 dB (𝑃 = 0.80)
abutment, the difference is small (10.8% points for Magnet
3 and 12.8% points for Magnet 5) and not statistically signif-
icant. The drop is even smaller than that for the “Testband”
transmission path, which is used frequently by audiologists
for preoperative testing. As a consequence, preoperative tests
with a testband should be useful and valid predictors for the
postoperative outcome with the Baha Attract system.
The additional attenuation of the Baha Attract system
increases from around 5 dB at 1 kHz to 20–25 dB at 6 to 8 kHz,
when compared to the abutment (Figure 4). In contrast,
speech reception scores show only a relatively small drop.
The probable reason for this difference is suggested by
the aided sound field thresholds in Figure 5. As the sound
processor was fitted for each transmission path separately,
there is a good compensation of the additional attenuation
for frequencies up to approximately 3000Hz. For 4000Hz
to 8000Hz, there is still a partial compensation. Thus a
large portion of the frequency spectrum which is important
for speech understanding remains almost unaffected. Con-
sequently, speech understanding scores can be reasonably
expected to remain high in Baha Attract users.
All tests were performed with two different magnets.
No significant difference between the two magnets (3 and
5) was found in any of the tests (BC Direct, aided sound
field thresholds, speech understanding in quiet, and speech
understanding in noise; Figures 4 to 7). A probable reason
for this finding is that the thickness of the artificial skin is not
affected significantly by the pressure of the magnets. Young’s
modulus of the skin sample was estimated to be around
83000N/m2 (±11%) from a series of simple measurements.
The relatively low pressures of less than 2200N/m2 even by
Magnet 5 will therefore cause a compression of 0.15mm or
less. This small deformation does not change the density or
elastic properties of the skin sample significantly.
This raises the following question: how realistic the exper-
imental setup with the artificial skin depicted in Figure 2(b)
is. Figure 4 shows the frequency dependent attenuation
through the system, measured psychoacoustically using the
BC Direct method. It can be seen that thresholds are not
significantly different from the attenuation of the patients’
own, real skin with the testband in the same figure. Similar
frequency dependences andmagnitudes of the sound attenu-
ation of real skin in patients have also been published earlier
by other groups (e.g., [17, 21]). This suggests that the artificial
skin does indeed mimic real skin reasonably well.
It is known that skin thickness behind the ear does
vary between patients [10], but different skin thicknesses
were not compared in this investigation. The thickness of
the artificial skin (5.6mm) used in this study is close to
the maximum thickness (6mm) of soft tissue recommended
by the manufacturer. For higher values, the manufacturer
recommends soft tissue thinning. Preliminary trials with a
double layer of the artificial skin, which would then corre-
spond roughly to the upper limit of the skin thickness found
on the mastoid [10], showed that even the strongest magnet
currently available could not hold the sound processor in
place sufficiently.
Our comparisons of the two patient groups (SSD and
MIX) suggest that there are no significant differences in how
hearing and speech understanding are affected by switching
8 BioMed Research International
from a skin penetrating abutment to a nonskin penetrating
Baha Attract transmission path. These findings confirm that
it is admissible to group the data of the two populations for
analysis. More importantly, however, they suggest that there
is currently no reason to limit the Attract system to only one
of these patient groups.
5. Conclusion
The nonskin penetrating Baha Attract system offers a new
approach of partially implantable bone conduction hearing
aids. In the preimplantation tests reported here, it was
found that there is an additional attenuation, ranging from
approximately 5 dB at 1000Hz to 20–25 dB above 6000 kHz,
when compared to the conventional transmission path using
an abutment. However, aided sound field hearing thresholds
show that a substantial part of this attenuation, mainly in
the frequency range up to 3000Hz, can be compensated
by the individual fitting of the sound processor. This is a
probable explanation for the relatively minor and statistically
nonsignificant differences in speech understanding in quiet
and in noise between the two different transmission paths.
The loss in speech understanding is even smaller than that
for the transmission through a testband, a method that
is commonly used preoperatively to test the system. On
the basis of this preimplantation trial, it can be reasonably
expected that the nonskin penetrating Baha Attract system
will be useful and beneficial for patients.
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